Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
The ARRIVE Study (Aspirin to Reduce Risk of Initial Vascular Events) - A Randomized, Double-Blind, Placebo Controlled, Multicenter, Parallel Group Study to Assess the Efficacy (Reduction of Cardiovascular Disease Events) and Safety of 100 mg Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease https://www.kusajili.fr:443/Trial/qrJZKaIQYE-99hsBqmavNQ%24the-arrive-study-aspirin-to-reduce-risk-of-initial-vascular-events---a-randomized-double-blind-placebo-controlled-multicenter-p
I have read and accept the terms of use of the site and the Privacy Policy
Send your message